Literature DB >> 2051739

Role of iron metabolism in absorption and cellular uptake of aluminum.

J B Cannata1, I Fernández-Soto, M J Fernández-Menendez, J L Fernández-Martín, S J McGregor, J H Brock, D Halls.   

Abstract

The effect of iron status on aluminum (Al) absorption was investigated in this study in vivo using an animal model and in vitro using an intestinal mucosal cell line. In the in vivo model rats were rendered iron overloaded by intraperitoneal injection of iron dextran (5 mg/48 hr) or iron deficient by phlebotomy (2.5 to 3 ml blood/week). These rats, and normal controls, were then dosed with Al(OH)3 (40 mg/day) for 30 days. Urinary excretion of Al was significantly greater in the iron deficient group than in the other two groups throughout the study period, and brain Al at the end of the experiment was significantly increased in the iron depleted group (1.93 micrograms/g) and decreased in the iron overloaded group (0.73 microgram/g) compared with controls (1.42 micrograms/g). The brain Al levels in iron overloaded rats were no higher than those in normal rats that had not been dosed with Al(OH)3 (0.61 microgram/g). No significant differences were found in serum Al levels. In the in vitro experiments cultures of the rat intestinal cell line RIE1 were iron overloaded by addition of iron nitrilotriacetate (0.1 mM) or iron depleted with desferrioxamine (5 micrograms/ml) for 20 days prior to pulsing with Al transferrin (0.5 mg/ml) for 24 hours. Uptake of Al was significantly greater in the iron depleted cells (2.3 ng/micrograms cell DNA) than in iron overloaded (0.81 ng) or untreated (0.83 microgram) cells. These studies show that iron depletion markedly increases absorption and cellular uptake and suggest that susceptible individuals, such as renal failure patients, run an increased risk of toxicity if they are iron deficient.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2051739     DOI: 10.1038/ki.1991.98

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  The role of transferrin and citrate in cellular uptake of aluminium.

Authors:  S J McGregor; J H Brock; D Halls
Journal:  Biol Met       Date:  1991

3.  Quantitative elemental analysis on aluminum accumulation by HVTEM-EDX in liver tissues of mice orally administered with aluminum chloride.

Authors:  Kiyokazu Kametani; Tetsuji Nagata
Journal:  Med Mol Morphol       Date:  2006-06       Impact factor: 2.309

4.  Absorbed aluminium is found with two cytosolic protein fractions, other than ferritin, in the rat duodenum.

Authors:  M Cochran; G Goddard; G Ramm; N Ludwigson; J Marshall; J Halliday
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

5.  Hippocampal tin, aluminum and zinc in Alzheimer's disease.

Authors:  F M Corrigan; G P Reynolds; N I Ward
Journal:  Biometals       Date:  1993       Impact factor: 2.949

Review 6.  The biological speciation and toxicokinetics of aluminum.

Authors:  E DeVoto; R A Yokel
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.